Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets

Hot-melt extruded (HME) filaments are an essential intermediate product for the threedimensional (3D) printing of drug delivery systems (DDSs) by the fused deposition modelling (FDM) process. The aim of this study was to design novel polymeric 3D-printable HME filaments loaded with active pharmaceutical ingredients (APIs). The physical solid-state properties, mechanical properties, drug release and short-term storage stability of the filaments and 3D-printed DDSs were studied. Physical powder mixtures of polycaprolactone (PCL), plasticizer and API were manually blended, extruded by a single-screw extruder, and printed by a table-top FDM 3D-printing system. The composition of PCL and arabic gum (ARA) enabled the incorporation of 20%, 30% and 40% (w/ w) of indomethacin (IND) and theophylline (THEO) into the HME filaments. The uneven distribution of API throughout the filaments impaired 3D printing. The HME filaments loaded with 20% IND or THEO were selected for the further analysis and printing tests (the ratio of PCL, ARA and IND or THEO was 7:1:2, respectively). The IND filaments were yellowish, mechanically strong and flexible, and they had a uniform filament diameter and smooth outer surface. The filaments containing THEO were smooth and off-white. The 3D-printed tablets fabricated from IND or THEO-loaded filaments showed sustained drug release in vitro. The drug release rate, however, significantly increased by changing the geometry of 3D-printed tablets from a conventional tablet structure to an unorthodox lattice (honeycomb) structure. Overall, the combination of PCL and ARA provides an interesting novel polymeric carrier system for 3D-printable HME filaments and tablets.

Automated summary

Hot-melt extruded (HME) filaments are essential for 3D printing drug delivery systems (DDS) using fused deposition modelling (FDM). This study designed novel polymeric HME filaments loaded with active pharmaceutical ingredients (APIs), and investigated their physical properties, mechanical properties, drug release, and short-term stability. The combination of polycaprolactone (PCL) and arabic gum (ARA) showed promise as a carrier system for 3D-printable HME filaments and tablets, with sustained drug release observed in vitro.